HHS Secretary Azar Likely To Advance Medicare Drug Pricing Policies

 
• By Cathy Kelly
  
Alex Azar, Trump’s HHS secretary nominee, who spoke at the Senate HELP committee 11/29/17
Alex Azar testifies at his confirmation hearing before the Senate HELP Committee on Nov. 29, 2017.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access